Drug Product Tracing: The Effect of Section 585 of the FD&C Act
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 3, 2022
November 5, 2024
34847c6a-61d4-4e1e-838f-dad6e160e8c3
Related Documents
Product Identifier Requirements Under the Drug Supply Chain Security Act – Compliance Policy Guidance for Industry
Guidance DocumentSeptember 20, 2018Center for Drug Evaluation and Research
General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry
Guidance DocumentJuly 27, 2022Center for Drug Evaluation and Research
Verification Systems Under the Drug Supply Chain Security Act for Certain Prescription Drugs: Guidance for Industry
Guidance DocumentDecember 7, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.